Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
Over a 12-month treatment period, the savings add up to $936 to $2,436
It was approved by the FDA in 2017 for the treatment of type 2 diabetes and later gained attention for its weight loss benefits
Its primary mechanisms include regulating actin, a structural protein important for cell shape, movement, and division, promoting cell migration to injury sites, reducing inflammation through downregulation of pro-inflammatory cytokines, and supporting stem cell maturation and differentiation
Furthermore, in a mouse model of non-alcoholic steatohepatitis, further studies indicated that linagliptin improves insulin sensitivity and hepatic steatosis in mice with diet-induced obesity (161) and ameliorates liver inflammation (162)
However, these tests are to be used in a logical, consequential and cost-effective manner